Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3787
Publisher
MDPI AG
Online
2020-12-16
DOI
10.3390/cancers12123787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GASP‐2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP‐1 transgenics
- (2020) Alexis Parenté et al. FASEB JOURNAL
- Interleukin‐4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma‐bearing mice
- (2020) Domiziana Costamagna et al. Journal of Cachexia Sarcopenia and Muscle
- Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data
- (2020) Harpreet Kaur et al. Frontiers in Genetics
- Management of Cancer Cachexia: ASCO Guideline
- (2020) Eric J. Roeland et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
- (2020) Keizo Takenaga et al. PLoS One
- Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
- (2020) Kevin G Burfeind et al. eLife
- Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia
- (2020) Surendra K. Shukla et al. CANCER LETTERS
- The Undiagnosed Disease Burden Associated with Alpha-1 Antitrypsin Deficiency Genotypes
- (2020) Tomoko Nakanishi et al. EUROPEAN RESPIRATORY JOURNAL
- Antibody-mediated inhibition of GDF15–GFRAL activity reverses cancer cachexia in mice
- (2020) Rowena Suriben et al. NATURE MEDICINE
- Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients
- (2020) Hong Peng et al. Cancers
- ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
- (2020) Joshua R. Huot et al. Journal of Cachexia Sarcopenia and Muscle
- Novel molecular targets of muscle wasting in cancer patients
- (2019) Janice Miller et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis
- (2019) Reith R. Sarkar et al. Journal of the National Comprehensive Cancer Network
- Unintentional weight loss, its associated burden, and perceived weight status in people with cancer
- (2019) Eva Y. N. Yuen et al. SUPPORTIVE CARE IN CANCER
- Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
- (2019) Patrick Naumann et al. Cancers
- Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
- (2019) Oonagh M. Griffin et al. PANCREATOLOGY
- The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
- (2019) Xiaoling Zhong et al. Journal of Cachexia Sarcopenia and Muscle
- CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Quality of Life and Treatment Outcomes of Patients with Chronic Pancreatitis and Pancreatic Cancer
- (2019) Edita Bieliuniene et al. Medicina-Lithuania
- Modeling Human Cancer-induced Cachexia
- (2019) Erin E. Talbert et al. Cell Reports
- The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
- (2019) Katherine A. Michaelis et al. Nature Communications
- Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
- (2019) Patrick Naumann et al. Cancers
- Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
- (2019) Oleg Blyuss et al. BRITISH JOURNAL OF CANCER
- Undulating changes in human plasma proteome profiles across the lifespan
- (2019) Benoit Lehallier et al. NATURE MEDICINE
- Plasma proteomic signature of age in healthy humans
- (2018) Toshiko Tanaka et al. AGING CELL
- Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer
- (2018) Olga Prokopchuk et al. BMC CANCER
- Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
- (2018) Nora Mattila et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
- (2018) Nilabja Sikdar et al. CURRENT GENOMICS
- CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage
- (2018) Kuan Hu et al. Translational Oncology
- Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
- (2018) Angie M. Y. Shum et al. Oncotarget
- Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer
- (2018) Joshua K. Kays et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
- (2018) Talia Golan et al. Journal of Cachexia Sarcopenia and Muscle
- Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
- (2018) Markus Kieler et al. MEDICAL ONCOLOGY
- Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent
- (2017) C. J. Reddel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Predictors of Pancreatic Cancer–Associated Weight Loss and Nutritional Interventions
- (2017) Laura Nemer et al. PANCREAS
- Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice
- (2017) Jacob L. Brown et al. Journal of Cachexia Sarcopenia and Muscle
- The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia
- (2017) Ernie D. Au et al. Frontiers in Physiology
- Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
- (2017) Andrea Bonetto et al. Frontiers in Physiology
- Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia
- (2016) Claudia A Penafuerte et al. BRITISH JOURNAL OF CANCER
- A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy
- (2016) Qi Qi et al. CANCER
- Cell death, clearance and immunity in the skeletal muscle
- (2016) C Sciorati et al. CELL DEATH AND DIFFERENTIATION
- Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma
- (2016) A Miller et al. ONCOGENE
- STAT3 in the systemic inflammation of cancer cachexia
- (2016) Teresa A. Zimmers et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Human Skeletal Muscle Proteome Project: a reappraisal of the current literature
- (2016) Marta Gonzalez-Freire et al. Journal of Cachexia Sarcopenia and Muscle
- The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
- (2016) Andrea Bonetto et al. Jove-Journal of Visualized Experiments
- The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer
- (2016) Eun Young Kim et al. PLoS One
- Wnt/β-Catenin Signaling Contributes to Skeletal Myopathy in Heart Failure via Direct Interaction With Forkhead Box OCLINICAL PERSPECTIVE
- (2015) Katsuki Okada et al. Circulation-Heart Failure
- Role of Activin A and Myostatin in Human Cancer Cachexia
- (2015) Audrey Loumaye et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss
- (2015) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism
- (2015) Hyeong-Kyu Park et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer
- (2015) Qiang Yi et al. TUMOR BIOLOGY
- GDF15 promotes EMT and metastasis in colorectal cancer
- (2015) Chen Li et al. Oncotarget
- MAP3K11/GDF15 axis is a critical driver of cancer cachexia
- (2015) Lorena Lerner et al. Journal of Cachexia Sarcopenia and Muscle
- Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
- (2015) Lorena Lerner et al. Journal of Cachexia Sarcopenia and Muscle
- FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration
- (2015) Alessandra Castiglioni et al. PLoS One
- Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer
- (2014) Yutaka Fujiwara et al. PLoS One
- Role of interleukin-6 in cachexia
- (2014) Aditi A. Narsale et al. Current Opinion in Supportive and Palliative Care
- Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
- (2014) John C Rohloff et al. Molecular Therapy-Nucleic Acids
- Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
- (2013) Yhun Yhong Sheen et al. Biomolecules & Therapeutics
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
- (2012) Andrea Bonetto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis
- (2011) Andreas Keller et al. RNA Biology
- Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
- (2010) James A. Carson et al. EXERCISE AND SPORT SCIENCES REVIEWS
- The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer
- (2010) Ozgur Kemik et al. World Journal of Surgical Oncology
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now